Literature DB >> 30052265

Standardization of Acrylic Bone Cement Mixing Protocols for Total Knee Arthroplasty Results in Cost Savings.

James R Kee, Simon C Mears, Paul K Edwards, Marty Bushmiaer, C Lowry Barnes.   

Abstract

Cost reduction is important in total joint replacement surgery. Bone cement is used to fixate implants in most knee replacement procedures. The authors instituted a 4-pronged approach to reduce the cost of cement. Their approach included reducing the cost of the cement powder, changing the type of mixing method, using less antibiotic cement, and decreasing the amount of cement required for smaller implants. The authors evaluated the implementation of this program and measured the overall costs of cementation during knee replacement. A retrospective review of total knee replacement cementation technique and cost was performed before and after the cost-reduction program was implemented. The type of cement and cement mixing equipment used, the amount of cement used, and the cost of cement and cement mixing equipment were examined. The authors also reported the short-term complication rate including 90-day readmission rate and 30-day revision rate. The program resulted in an overall decrease in cement-related costs from approximately $310 to $105 per case. Reductions in the amount of cement used and the use of antibiotic cement were shown. Among the 3 surgeons, adoption of the program varied. Bone cement is an expense of modern total knee replacement. Implementing a cost-reduction program can reduce cement costs without changing quality of cementation. [Orthopedics. 2018; 41(5):e671-e675.]. Copyright 2018, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30052265     DOI: 10.3928/01477447-20180724-01

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  1 in total

1.  Comparative Study of Antibiotic Elution Profiles From Alternative Formulations of Polymethylmethacrylate Bone Cement.

Authors:  Daniel G Meeker; Kasa B Cooper; Regis L Renard; Simon C Mears; Mark S Smeltzer; C Lowry Barnes
Journal:  J Arthroplasty       Date:  2019-03-12       Impact factor: 4.757

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.